NDC 68788-4052 – Amitriptyline Hydrochloride
Amitriptyline Hydrochloride 100 mg/1 · Tablet · Oral
Product NDC68788-4052
Product details
- Brand name
- Amitriptyline Hydrochloride
- Generic name
- Amitriptyline Hydrochloride
- Labeler
- Preferred Pharmaceuticals Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA217411
- Marketed since
- November 17, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Tricyclic Antidepressant
Active ingredients
- Amitriptyline Hydrochloride 100 mg/1
Uses, dosage, side effects and warnings for Amitriptyline Hydrochloride →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 68788-4052-3 | 30 TABLET in 1 BOTTLE (68788-4052-3) | Nov 17, 2025 |
| 68788-4052-6 | 60 TABLET in 1 BOTTLE (68788-4052-6) | Nov 17, 2025 |
| 68788-4052-8 | 28 TABLET in 1 BOTTLE (68788-4052-8) | Nov 17, 2025 |
| 68788-4052-9 | 90 TABLET in 1 BOTTLE (68788-4052-9) | Nov 17, 2025 |
Other Amitriptyline Hydrochloride products
- 50090-7598 Amitriptyline Hydrochloride 50 mg/1 · Tablet · A-S Medication Solutions
- 50090-7583 Amitriptyline Hydrochloride 100 mg/1 · Tablet · A-S Medication Solutions
- 50090-8033 Amitriptyline Hydrochloride 25 mg/1 · Tablet · A-S Medication Solutions
- 80425-0395 Amitriptyline Hydrochloride 25 mg/1 · Tablet · Advanced Rx of Tennessee, LLC
- 80425-0434 Amitriptyline Hydrochloride 50 mg/1 · Tablet · Advanced Rx of Tennessee, LLC
- 80425-0439 Amitriptyline Hydrochloride 100 mg/1 · Tablet · Advanced Rx of Tennessee, LLC
- 11788-082 Amitriptyline Hydrochloride 150 mg/1 · Tablet · AiPing Pharmaceutical, Inc.
- 11788-077 Amitriptyline Hydrochloride 10 mg/1 · Tablet · AiPing Pharmaceutical, Inc.
- 11788-078 Amitriptyline Hydrochloride 25 mg/1 · Tablet · AiPing Pharmaceutical, Inc.
- 11788-079 Amitriptyline Hydrochloride 50 mg/1 · Tablet · AiPing Pharmaceutical, Inc.
- 11788-080 Amitriptyline Hydrochloride 75 mg/1 · Tablet · AiPing Pharmaceutical, Inc.
- 11788-081 Amitriptyline Hydrochloride 100 mg/1 · Tablet · AiPing Pharmaceutical, Inc.